- New Purchases: GHRS, VIRX, RAIN, JANX, IKNA, DAWN, NGM, ACRS, SLN, ANGN, FLACU, EUCRU, FVAM, JYAC, RZLT, CNTA, CRNX,
- Added Positions: ARGX, SNDX, RCUS, FDMT, RACA, REPL, ACIU, CTIC, CALA, ERYP, RLAY, CDTX, CRVS, IMVT, CFRX, OVID,
- Reduced Positions: XENE, RVMD, EPIX, CGEM, ANAB, PTGX, FBRX, SELB, VRDN, XFOR, FWP, VSTM, PIRS, MEIP, GRTS,
- Sold Out: FPRX, IONS, IDYA, CTMX,
For the details of BVF INC's stock buys and sells, go to https://www.gurufocus.com/guru/bvf+inc/current-portfolio/portfolio
These are the top 5 holdings of BVF INC- GH Research PLC (GHRS) - 9,275,156 shares, 7.55% of the total portfolio. New Position
- argenx SE (ARGX) - 651,204 shares, 7.35% of the total portfolio. Shares added by 110.34%
- Olema Pharmaceuticals inc (OLMA) - 6,661,503 shares, 6.99% of the total portfolio.
- Protagonist Therapeutics Inc (PTGX) - 3,754,095 shares, 6.31% of the total portfolio. Shares reduced by 5.19%
- Merus NV (MRUS) - 7,285,071 shares, 5.75% of the total portfolio.
Bvf Inc initiated holding in GH Research PLC. The purchase prices were between $19.25 and $21.73, with an estimated average price of $20.43. The stock is now traded at around $21.000000. The impact to a portfolio due to this purchase was 7.55%. The holding were 9,275,156 shares as of 2021-06-30.
New Purchase: Viracta Therapeutics Inc (VIRX)Bvf Inc initiated holding in Viracta Therapeutics Inc. The purchase prices were between $7.55 and $12.95, with an estimated average price of $10.02. The stock is now traded at around $9.620000. The impact to a portfolio due to this purchase was 1.32%. The holding were 3,094,174 shares as of 2021-06-30.
New Purchase: Rain Therapeutics Inc (RAIN)Bvf Inc initiated holding in Rain Therapeutics Inc. The purchase prices were between $15.08 and $20.3, with an estimated average price of $17.57. The stock is now traded at around $17.940000. The impact to a portfolio due to this purchase was 1.13%. The holding were 1,945,949 shares as of 2021-06-30.
New Purchase: Janux Therapeutics Inc (JANX)Bvf Inc initiated holding in Janux Therapeutics Inc. The purchase prices were between $18.58 and $25.37, with an estimated average price of $22.27. The stock is now traded at around $29.520000. The impact to a portfolio due to this purchase was 1.1%. The holding were 1,176,681 shares as of 2021-06-30.
New Purchase: Ikena Oncology Inc (IKNA)Bvf Inc initiated holding in Ikena Oncology Inc. The purchase prices were between $13.27 and $28.25, with an estimated average price of $18.64. The stock is now traded at around $11.850000. The impact to a portfolio due to this purchase was 0.93%. The holding were 1,767,399 shares as of 2021-06-30.
New Purchase: Day One Biopharmaceuticals Inc (DAWN)Bvf Inc initiated holding in Day One Biopharmaceuticals Inc. The purchase prices were between $19 and $25.89, with an estimated average price of $20.97. The stock is now traded at around $27.000000. The impact to a portfolio due to this purchase was 0.78%. The holding were 918,975 shares as of 2021-06-30.
Added: argenx SE (ARGX)Bvf Inc added to a holding in argenx SE by 110.34%. The purchase prices were between $257.11 and $319.92, with an estimated average price of $284.1. The stock is now traded at around $343.250000. The impact to a portfolio due to this purchase was 3.86%. The holding were 651,204 shares as of 2021-06-30.
Added: Syndax Pharmaceuticals Inc (SNDX)Bvf Inc added to a holding in Syndax Pharmaceuticals Inc by 1420.53%. The purchase prices were between $13.42 and $25.18, with an estimated average price of $18.46. The stock is now traded at around $16.810000. The impact to a portfolio due to this purchase was 1.49%. The holding were 2,486,429 shares as of 2021-06-30.
Added: Arcus Biosciences Inc (RCUS)Bvf Inc added to a holding in Arcus Biosciences Inc by 49.13%. The purchase prices were between $22.75 and $35.77, with an estimated average price of $28.5. The stock is now traded at around $28.950000. The impact to a portfolio due to this purchase was 0.95%. The holding were 2,797,822 shares as of 2021-06-30.
Added: 4D Molecular Therapeutics Inc (FDMT)Bvf Inc added to a holding in 4D Molecular Therapeutics Inc by 94.54%. The purchase prices were between $22.2 and $43.38, with an estimated average price of $30.89. The stock is now traded at around $30.120000. The impact to a portfolio due to this purchase was 0.88%. The holding were 2,005,862 shares as of 2021-06-30.
Added: Therapeutics Acquisition Corp (RACA)Bvf Inc added to a holding in Therapeutics Acquisition Corp by 258.99%. The purchase prices were between $9.91 and $10.54, with an estimated average price of $10.18. The stock is now traded at around $10.274300. The impact to a portfolio due to this purchase was 0.77%. The holding were 2,772,226 shares as of 2021-06-30.
Added: Replimune Group Inc (REPL)Bvf Inc added to a holding in Replimune Group Inc by 99.15%. The purchase prices were between $28.5 and $39.37, with an estimated average price of $34.17. The stock is now traded at around $31.170000. The impact to a portfolio due to this purchase was 0.66%. The holding were 918,928 shares as of 2021-06-30.
Sold Out: (FPRX)Bvf Inc sold out a holding in . The sale prices were between $37.65 and $38, with an estimated average price of $37.89.
Sold Out: Ionis Pharmaceuticals Inc (IONS)Bvf Inc sold out a holding in Ionis Pharmaceuticals Inc. The sale prices were between $34.54 and $47.25, with an estimated average price of $39.32.
Sold Out: IDEAYA Biosciences Inc (IDYA)Bvf Inc sold out a holding in IDEAYA Biosciences Inc. The sale prices were between $17.76 and $24.83, with an estimated average price of $20.63.
Sold Out: CytomX Therapeutics Inc (CTMX)Bvf Inc sold out a holding in CytomX Therapeutics Inc. The sale prices were between $6.33 and $9.91, with an estimated average price of $7.78.
Here is the complete portfolio of BVF INC. Also check out:
1. BVF INC's Undervalued Stocks
2. BVF INC's Top Growth Companies, and
3. BVF INC's High Yield stocks
4. Stocks that BVF INC keeps buying
